58  Total SME IPOs listed in 2025

2,593.84 Crs.  Total funds raised in 2025

40  SME IPOs listed with Gain in 2025

18  SME IPOs listed with loss in 2025

58  Total SME IPOs listed in 2025

2593.84 Crs.  Total funds raised in 2025

40  SME IPOs listed with Gain in 2025

18  SME IPOs listed with loss in 2025

58  Total SME IPOs listed in 2025

2593.84 Crs.  Total funds raised in 2025

40  SME IPOs listed with Gain in 2025

18  SME IPOs listed with loss in 2025

58  Total SME IPOs listed in 2025

2593.84 Crs.  Total funds raised in 2025

40  SME IPOs listed with Gain in 2025

18  SME IPOs listed with loss in 2025

SMS Pharmaceuticals Limited IPO (SMS Pharmaceuticals IPO) Details

SMS Pharmaceuticals Limited is an Pharmaceutical based company, located in Hyderabad, SMS Pharmaceuticals Limited IPO size was 97.93 Cr. and was issued at 380.00 per share. The share of SMS Pharmaceuticals Limited were listed at 357.85 per share and are currently trading at 217.06 per share.

Type :
Sub Sector : Manufacturing Of APIs
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
195.26 Cr.

PAT :
21.20 Cr.

Pricing Report

Issue Price :
380.00

Listing Price :
357.85

Current Market Price :
217.06

Issue Price vs CMP :
179.06 (471.21%)

listing Price vs CMP :
181.275 (506.57%)

Performance Report (CAGR* wise)

CAGR : 10.08
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.

About SMS Pharmaceuticals

Company Information
SMS Pharmaceuticals Limited, one of the leading manufacturers and exporters of Active Pharma Ingredients and pharmaceutical intermediates in India, commonly known as Bulk Drug Manufacturer. They are mainly engaged in manufacturing bulk drugs like Ranitidine HCl, Sumatriptan Succinate, Sildenofil Citrate, Omeprazole Magnesium, Ramipril, Almotriptan maleate, Gemcitabine HCl, Imatinib Mesilate and their intermediates. They have also started producing ACE Inhibitors like Perindopril Erubamine and Imidapril and anti- cancer drug Capecitabine and Bicalutamide. They believe they are one of the largest producers of Ranitidine HCl in the world. They have an integrated manufacturing facility, professional skilled workforce, R&D expertise and an ever-expanding array of API's and Bulk Intermediates. They have also established exclusive basic research facility where they develop new products and carry on process improvements.
Object of Issue
  • Setting up of facilities for manufacturing Active Pharmaceuticals Ingredients (APIs at Kandivalsa Village, Vizianagaram District, Andhra Pradesh
  • To meet the requirement for Additional Working Capital

SMS Pharmaceuticals MainBoard IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
Feb, 2007
IPO Size :
97.93 Cr.
PE Multiple :
17.35
Merchant Banker :
Uti Securities Limited
IPO Registrar:
Aarthi Consultants Private Limited.
Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

See Other MainBoard IPOs in Hyderabad

Quality Power Electrical Equipments Limited

  Manufactures critical high-voltage equipment for High Voltage Direct Current (HVDC) and Flexible AC Transmission Systems (FACTS) networks, enabling energy transition from renewable sources to power gr

  Sangli


Hexaware Technologies Limited

  business of global digital and technology services with artificial intelligence.

  Mumbai


Ajax Engineering Limited

  SLCM machinery that are widely used in infra developments

  Bangalore


Dr Agarwals Health Care Limited

  comprehensive range of eye care services

  Chennai


Denta Water and Infra Solutions Limited

  water and infrastructure solutions company

  Bangalore


Peer Companies Of This Sector

FAQs

SMS Pharmaceuticals operates in Pharmaceutical and Manufacturing Of APIs. The Issue is listed on BSE,NSE in Feb, 2007. SMS Pharmaceuticals IPO size was 97.93 Cr. with Issue price of 380.00 .

Merchant Banker(s) of SMS Pharmaceuticals IPO: Uti Securities Limited

SMS Pharmaceuticals IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

SMS Pharmaceuticals IPO listed at a listing price of 357.85 against the offer price of 380.00.

The current market price of SMS Pharmaceuticals is 217.06.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency